-+ 0.00%
-+ 0.00%
-+ 0.00%

NRX PHARMACEUTICALS - ON JULY 21, NRXD SELECTED BY DARPA FOR NEGOTIATION OF POTENTIAL SPARC-TMS CLINICAL TRIAL AWARD - SEC FILING

Reuters·07/22/2026 11:08:31

Please log in to view news